MindWalk Holdings (HYFT) Common Equity (2020 - 2026)
MindWalk Holdings (HYFT) reported Common Equity of $10.7 million for Q1 2026, down 39.5% year-over-year from $17.7 million in Q1 2025, and down 16.1% quarter-over-quarter from $12.8 million in Q4 2025.
MindWalk Holdings (HYFT) Common Equity (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Common Equity data on file, last reported at $10.7 million in Q1 2026.
- Common Equity for Q1 2026 came in at $10.7 million, down 39.5% year-over-year; the trailing twelve-month figure through Jan 2026 was $10.7 million (down 39.5% YoY), and the FY2025 annual result was $16.9 million, up 8.68% from the prior year.
- Common Equity eased to $10.7 million in Q1 2026 per HYFT's latest filing, from $12.8 million in the prior quarter.
- Over five years, Common Equity peaked at $59.4 million in Q2 2022 and troughed at $6.9 million in Q4 2022.
- A 5-year average of $23.0 million and a median of $15.5 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 83.07% in 2022, then soared 459.78% in 2023.
- A 5-year view of Common Equity shows it stood at $6.9 million in 2022, then soared by 459.78% to $38.4 million in 2023, then tumbled by 69.97% to $11.5 million in 2024, then increased by 10.75% to $12.8 million in 2025, then slipped by 16.1% to $10.7 million in 2026.
- Business Quant data shows HYFT's Common Equity at $10.7 million in Q1 2026, $12.8 million in Q4 2025, and $15.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 10.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 10.71 Mn |
| Oct 31, 2025 | 12.76 Mn |
| Jul 31, 2025 | 15.10 Mn |
| Apr 30, 2025 | 16.51 Mn |
| Jan 31, 2025 | 17.70 Mn |
| Oct 31, 2024 | 11.52 Mn |
| Jul 31, 2024 | 23.99 Mn |
| Apr 30, 2024 | 15.52 Mn |
| Jan 31, 2024 | 12.49 Mn |
| Oct 31, 2023 | 38.37 Mn |
| Jul 31, 2023 | 40.34 Mn |
| Apr 30, 2023 | 43.24 Mn |
| Jan 31, 2023 | 7.69 Mn |
| Oct 31, 2022 | 6.86 Mn |
| Jul 31, 2022 | 51.50 Mn |
| Apr 30, 2022 | 59.44 Mn |
| Jan 31, 2022 | 7.07 Mn |
| Oct 31, 2021 | 40.49 Mn |
| Jul 31, 2021 | 45.13 Mn |
| Apr 30, 2021 | 45.21 Mn |